BA
RGLS

BlackRock Advisors’s Regulus Therapeutics RGLS Stock Holding History

BlackRock Advisors’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$39K Sell
143
-20
-12% -$6.5K ﹤0.01% 3311
2016
Q3 		$64K Buy
163
+29
+22% +$11.9K ﹤0.01% 3180
2016
Q2 		$47K Buy
134
+29
+28% +$20.8K ﹤0.01% 3245
2016
Q1 		$88K Hold
105
– – ﹤0.01% 2977
2015
Q4 		$110K Sell
105
-43
-29% -$43.1K ﹤0.01% 2879
2015
Q3 		$116K Sell
148
-2
-1% -$2.05K ﹤0.01% 3029
2015
Q2 		$197K Buy
150
+64
+74% +$103K ﹤0.01% 2798
2015
Q1 		$174K Buy
86
+12
+16% +$26.1K ﹤0.01% 2759
2014
Q4 		$142K Sell
74
-1,576
-96% -$2.8M ﹤0.01% 2845
2014
Q3 		$1.35M Sell
1,650
-192
-10% -$162K ﹤0.01% 1296
2014
Q2 		$1.78M Buy
1,842
+3
+0.2% +$2.57K ﹤0.01% 1208
2014
Q1 		$1.99M Buy
1,839
+582
+46% +$645K ﹤0.01% 1177
2013
Q4 		$1.11M Buy
1,257
+1,215
+2,893% +$1.05M ﹤0.01% 1443
2013
Q3 		$47K Buy
42
+5
+14% +$5.9K ﹤0.01% 3205
2013
Q2 		$44K Buy
+37
New +$35.2K ﹤0.01% 3192

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

BlackRock Advisors's RGLS Position: Q4 2016 in Review

BlackRock Advisors reduced its Regulus Therapeutics (RGLS) stake by 12% in Q4 2016, selling an estimated $6.5K and leaving 143 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #3311.

BlackRock Advisors first reported a position in RGLS in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.99M in Q1 2014. 68 funds tracked by Wall St. Rank hold RGLS as of Q4 2016.

  • BlackRock Advisors held 143 shares of Regulus Therapeutics worth $39K as of Q4 2016.
  • BlackRock Advisors sold 20 Regulus Therapeutics shares in Q4 2016, an estimated $6.5K.
  • Regulus Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3311 holding.
  • BlackRock Advisors first reported a position in Regulus Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Regulus Therapeutics position peaked at $1.99M in Q1 2014.
  • 68 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.